SPY300.77-2.20 -0.73%
DIA252.17-2.18 -0.86%
IXIC9,331.02-37.97 -0.41%

Dr Reddy's Laboratories Q4 EPS $0.610 Beats $0.490 Estimate, Sales $588.000M Up From $581.000M YoY

Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.610 per share which beat the analyst consensus estimate of $0.490 by 24.49 percent. This is a 60.53 percent increase over earnings of $0.380 per share

Benzinga · 05/20/2020 10:45

Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.610 per share which beat the analyst consensus estimate of $0.490 by 24.49 percent. This is a 60.53 percent increase over earnings of $0.380 per share from the same period last year. The company reported $588.000 million in sales this quarter. This is a 1.20 percent increase over sales of $581.000 million the same period last year.